🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803
The study compares Buventol® Easyhaler® and Bufomix® Easyhaler® to the curr...
Status
Completed
Location
Helsinki University Hospital
Start Date
2021-11-11
Trial ID
NCT05084222
The purpose of this study is to determine whether Symbicort dosed according...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00252863
Treatments Being Tested
The purpose of this study is to compare the early onset of effect of Symbic...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00646620
Treatments Being Tested
The purpose of this study is to evaluate the site and mechanisms responsibl...
Status
Recruiting
Location
Arthur F Gelb Medical Corporation
Start Date
2007-10
Trial ID
NCT01225913
This is a parallel-group, Phase 2, randomized, double-blind, placebo-contro...
Status
Active Not Recruiting
Location
The Center for Clinical Trials - Saraland- Site Number : 8400096
Start Date
2024-11-07
Trial ID
NCT06676319
This study aims to establish the treatment scheme of Yiqi Huoxue Huatan gra...
Status
Unknown
Location
Beijing Changping TCM Hospital
Start Date
2019-10-08
Trial ID
NCT04208581
Treatments Being Tested
The purpose of this study is to determine whether Symbicort compared with A...
Status
Completed
Location
Multiple Locations
Start Date
2003-11
Trial ID
NCT00646594
Treatments Being Tested
This study will evaluate the effects of budesonide (using Symbicort which i...
Status
Unknown
Location
St. Paul's Hospital
Start Date
2015-02
Trial ID
NCT02833480
Treatments Being Tested
The primary purpose of this study is to evaluate lung function and health r...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-25
Trial ID
NCT03478696